04/06/2016 - 11:32am

Activity trackers are not considered approved medical devices, however, the increased use of these devices has the potential to provide emergency physicians with objective clinical information, doctor says.

04/06/2016 - 11:05am

The Migraine Experience is the first simulator designed to give non-sufferers the chance to safely experience symptoms of a migraine including disorientation, aura, sensitivity to light and blurred vision. 

04/06/2016 - 10:53am
Lupin received final approval for Zolpidem Sublingual Tablets from the United States Food & Drug Administration earlier, as well as final clearance from the FTC with 180 days of exclusivity.
04/06/2016 - 10:35am

In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.

04/05/2016 - 11:40am

Truth's first foray into raising awareness around how second-hand smoke impacts pet health, "#CATmageddon," has already been viewed more than 33 million times.

04/05/2016 - 11:13am

Showcasing a more approachable personality, the brand's first advertising campaign in recent years is set to launch in April and will focus on reaching more casual athletes and weekend warriors. 

04/05/2016 - 10:46am

FDA warning letters barring the sale of products containing methylsynephrine  were welcomed by the Council for Responsible Nutrition, which represents dietary supplmement manufacturers and suppliers. 

04/04/2016 - 11:33am

McKesson has closed its $1.2 billion acquisitions of Biologics and Vantage Oncology, which the company had announced in February. 

04/03/2016 - 3:32pm

According to the 2015 National Institute on Drug Abuse’s annual Monitoring the Future survey, one in 30 teens abuses OTC cough medicine containing DXM to get high.